17873-58-4

Basic information

• Product Name: Tetrabenzo[a,d,g,j]cyclododecene,5,10,15,20-tetrahydro-2,3,7,8,12,13,17,18-octamethoxy-
• Synonyms: Cyclotetraveratrylene
• CAS NO: 17873-58-4
• Molecular Formula: C36H40 O8
• Molecular Weight: 600.709
• Mol File: 17873-58-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Tetrabenzo[a,d,g,j]cyclododecene,5,10,15,20-tetrahydro-2,3,7,8,12,13,17,18-octamethoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Tetrabenzo[a,d,g,j]cyclododecene,5,10,15,20-tetrahydro-2,3,7,8,12,13,17,18-octamethoxy-(17873-58-4)
• EPA Substance Registry System: Tetrabenzo[a,d,g,j]cyclododecene,5,10,15,20-tetrahydro-2,3,7,8,12,13,17,18-octamethoxy-(17873-58-4)

Safety Data

• Hazardous Substances Data: 17873-58-4(Hazardous Substances Data)

Upstream product

• 7306-46-9 4-chloromethyl-1,2-dimethoxy-benzene 
• 93-03-8 (3,4-dimethoxyphenyl)methanol 

Relevant articles and documents

An electron-transfer induced conformational transformation from non-cofacial "sofa" to cofacial "boat" in cyclotetraveratrylene (CTTV) and formation of charge transfer complexes

Electro-active polychromophoric assemblies that undergo clam-like electromechanic actuation represent an important class of organic functional materials. Here, we show that the readily available cyclotetraveratrylene (CTTV) undergoes oxidation-induced folding, consistent with interconversion from a non-cofacial "sofa" conformation to a cofacial "boat" conformer. It is found that the non-cofacial "sofa" conformer of CTTV forms stable electron donor-acceptor complexes with chloranil and DDQ. Electron-transfer induced conformational transformation in CTTV provides a framework for the rational design of novel organic functional molecules.

Cyclo-oligomerization of veratryl alcohol with triflouroacetic acid

Treatment of veratryl alcohol with a dilute solution of triflouroacetic acid in chloroform yields a mixture of oligomers. Four major products have been separated and identified as the new cyclohexaveratrylene 6 and cyclopentaveratrylene 5, in addition to the known cyclic tetramer 4 and cyclic trimer 3.